tiprankstipranks
Enveric Biosciences (ENVB)
NASDAQ:ENVB
Holding ENVB?
Track your performance easily

Enveric Biosciences (ENVB) Income Statement

448 Followers

Enveric Biosciences Income Statement

Last quarter (Q3 2024), Enveric Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Enveric Biosciences's net income was $-2.08M. See Enveric Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 39.91M
Cost of Revenue
------
Gross Profit
-----$ 39.91M
Operating Expense
$ 5.74M$ 18.30M$ 19.96M$ 64.62M$ 5.62M$ 2.30M
Operating Income
$ -8.84M$ -16.45M$ -27.42M$ -64.62M$ -5.62M$ -2.30M
Net Non Operating Interest Income Expense
$ 1.01K$ 3.71K$ -5.25K$ -10.32K$ -445.25K$ -81.82K
Other Income Expense
$ 1.20M$ 1.03M$ 9.30K$ -8.20M$ 802.11K$ -32.32K
Pretax Income
$ -9.83M$ -17.26M$ -19.96M$ -56.43M$ -6.86M$ -2.35M
Tax Provision
$ 24.05K$ 28.91K$ -1.49M$ -7.45M$ 5.06M$ 388.66K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -9.86M$ -17.46M$ -18.80M$ -48.98M$ -6.86M$ -2.35M
Basic EPS
$ -2.54$ -8.09$ -13.00$ -103.50$ -59.50$ -141.50
Diluted EPS
$ -2.54$ -8.09$ -13.00$ -103.50$ -59.50$ -141.50
Basic Average Shares
$ 22.58M$ 2.16M$ 1.45M$ 472.34K$ 115.07K$ 42.58K
Diluted Average Shares
$ 22.58M$ 2.16M$ 1.45M$ 472.34K$ 115.07K$ 42.58K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.89M$ 18.30M$ 19.96M$ 64.62M$ 5.62M$ 2.30M
Net Income From Continuing And Discontinued Operation
$ -9.83M$ -17.31M$ -18.50M$ -48.98M$ -6.86M$ -2.35M
Normalized Income
$ -7.19M$ -14.21M----
Interest Expense
------
EBIT
$ -5.70M$ -18.30M$ -19.95M$ -56.42M$ -6.42M$ -2.28M
EBITDA
$ -5.36M$ -17.89M$ -19.52M$ -55.74M$ -6.30M$ -2.21M
Currency in USD

Enveric Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis